…

The choice of dengue NS1 as the target analyte places this work within a clinically meaningful context that deserves closer examination. NS1 is a glycoprotein secreted by dengue virus-infected cells, and it circulates in the bloodstream of patients during the acute phase of infection, often at concentrations that overlap with the detection range reported here. Because NS1 can be detected in serum before the appearance of antibodies, it serves as an early marker of infection, which is precisely the window in which diagnostic platforms have the greatest practical value. The authors’ decision to test their platform in commercial human serum, rather than only in buffer, therefore addresses one of the most common failure modes of electrochemical biosensors: the loss of performance when the sensing surface encounters the proteins, salts, and competing molecules present in real biological matrices. The observation that sensitivity actually improved slightly in serum, from 0.18% ± 0.02% per decade in PBS to 0.21% ± 0.01% per decade, suggests that the self-assembled monolayer architecture provides a degree of protection against matrix effects, although the authors appropriately frame this as robustness rather than as evidence of enhanced selectivity in complex medium.

The composition of the sensing layer itself reflects a careful balance of functions that each component performs. The DNA aptamer serves as the biorecognition element, folding into a three-dimensional structure that binds NS1 with high affinity. The 6-mercapto-1-hexanol acts as a blocking agent, filling gaps in the monolayer to prevent nonspecific adsorption of proteins onto the gold surface, a step that is essential for maintaining low background signals in serum. The 6-ferrocenyl-hexanethiol introduces a covalently attached redox label directly into the monolayer, which is what allows the platform to operate without adding redox species to the solution. This last point distinguishes the present approach from many Faradaic electrochemical sensors, which rely on ferricyanide or similar redox couples dissolved in the electrolyte. By coupling the redox pair to the surface, the authors eliminate a source of variability and simplify the measurement protocol, since the electrochemical response arises entirely from the electrode/electrolyte interface rather than from diffusion-limited reactions in solution.

The optimization of the aptamer-to-thiol ratio provides insight into how surface density governs analytical performance. At the 1:50 condition, the aptamer molecules are sufficiently diluted among the thiol components to reduce steric crowding, which facilitates the conformational changes needed for aptamer-protein binding while preserving enough recognition sites per unit area to generate a measurable signal. When aptamers are packed too densely on a surface, their folded structures can interfere with one another, and bound proteins can block neighboring recognition sites, diminishing the effective response. Conversely, when aptamers are too sparse, the signal amplitude falls below practical thresholds. The 1:50 ratio represents the empirical optimum between these competing constraints, and the fact that the authors performed this optimization in quadruplicate and obtained analytical curves in sextuplicate indicates a level of statistical rigor that strengthens confidence in the reported figures of merit.

The use of electrochemical capacitance spectroscopy as the primary characterization technique merits additional discussion. While electrochemical impedance spectroscopy is the more established method for studying electrode interfaces, ECS focuses specifically on the capacitive component of the response as a function of frequency and potential. This focus offers advantages for biosensing applications because biomolecular binding events at the surface alter the dielectric properties and charge distribution of the electrode/electrolyte interface, producing changes in capacitance that can be tracked quantitatively. The redox pair attached to the monolayer serves as an internal reference for these measurements, allowing the authors to monitor how the capacitive response shifts as NS1 binds to the aptamer layer. The reported linear range of 0.01 to 1,000 ng/mL spans five orders of magnitude in concentration, which is notably broad for a protein biosensor and suggests that the capacitive transduction mechanism remains responsive across a wide range of surface coverage values.

The limits of detection reported here, 24.9 ng/mL in PBS and 25.8 ng/mL in serum, are closely matched between the two media, which reinforces the conclusion that the platform behaves consistently regardless of sample complexity. This consistency is not trivial. Many electrochemical biosensors exhibit substantial degradation of detection limits when moved from buffer to serum, as nonspecific protein adsorption and competing electrochemical reactions raise the background noise. The near-identical values obtained in this study indicate that the blocking strategy using 6-mercapto-1-hexanol, combined with the covalently attached redox label, effectively suppresses the sources of interference that typically plague capacitive measurements in biological fluids. The authors’ decision to report both sensitivity and detection limits with associated uncertainties, derived from the sum of squared deviations of data points from sample means, provides a transparent account of the measurement variability.

The reported decrease in long-term stability after 7 to 14 days is a practical consideration that shapes the potential deployment scenarios for this technology. Aptamer-based sensors are generally more stable than antibody-based platforms because DNA oligonucleotides resist denaturation better than proteins, but the monolayer itself can degrade over time through desorption of thiol components, oxidation of the ferrocene label, or gradual loss of aptamer conformational integrity. The authors’ observation that performance declined after this window suggests that the sensors are best suited for use within approximately one week of preparation, which is compatible with point-of-care manufacturing models where devices are produced shortly before use. Extending this stability window would require further optimization of the monolayer composition or the introduction of protective storage conditions, directions that the authors identify as priorities for future work.

The broader context of this study within the evolution of biosensor technology highlights how far the field has progressed since the early enzyme electrodes of the mid-twentieth century. The progression from millimolar detection of glucose to femtomolar detection of complex biomarkers reflects advances in biorecognition chemistry, surface functionalization, and transduction methods. The present work contributes to this trajectory by demonstrating that capacitive techniques, when combined with aptamer-based recognition and surface-coupled redox labels, can achieve clinically relevant detection of a viral protein in serum. The five-decade linear range and the consistency between buffer and serum performance suggest that the platform could be adapted to other protein targets by substituting the aptamer sequence, since the underlying transduction mechanism depends on the general principles of surface binding rather than on the specific identity of the analyte.

The authors’ framing of this work as a step toward integrating quantum-scale concepts into bioelectrochemical sensing connects the experimental results to a growing body of theoretical and computational research. As detection scales shrink and surface densities of recognition elements increase, the classical models used to interpret electrochemical data may require revision to account for phenomena such as quantization of energy levels at interfaces, stochastic charge accumulation, and quantum capacitance effects. The authors note that researchers are currently developing hypotheses and simulations to reinterpret charge blocking and accumulation in these terms, and to determine how such quantum-scale phenomena influence particle interactions in biosensing contexts. While the present study does not claim to demonstrate quantum effects directly, the use of ECS to characterize a surface-coupled redox monolayer provides an experimental framework in which such reinterpretations could eventually be tested, since the capacitive response of the electrode/electrolyte interface is sensitive to the electronic structure of the surface and the molecules attached to it.

The choice of gold electrodes with a 2 mm diameter provides a well-defined and reproducible sensing area, which is important for comparing results across replicate measurements and across different preparation batches. Gold is the standard substrate for thiol-based self-assembled monolayers because the gold-sulfur bond is strong and forms spontaneously under mild conditions, allowing the co-immobilization of aptamers and thiols without harsh chemical treatments. The incubation protocol, involving 16 hours at 4 degrees Celsius in a humid chamber followed by blocking with 6-mercapto-1-hexanol in 10% ethanol, reflects established practices for forming dense and ordered monolayers. The subsequent stabilization in PBS for one hour before measurement ensures that the surface reaches an equilibrium state, reducing drift during the analytical measurements.

The preparation of the aptamer samples, involving heating at 95 degrees Celsius for 10 minutes followed by gradual cooling over one hour, is a standard protocol for ensuring that the oligonucleotides fold into their thermodynamically stable conformations. This step is particularly important for aptamers, which rely on specific secondary and tertiary structures for target recognition. The use of TE buffer containing magnesium chloride in the immobilization step further supports proper folding, as divalent cations stabilize the folded structures of many DNA aptamers. The storage of both aptamers and NS1 protein at negative 40 degrees Celsius, with aliquoting to avoid repeated freeze-thaw cycles, reflects careful sample handling practices that preserve the integrity of the biological reagents throughout the experimental campaign.

The statistical treatment of the data, based on means and associated uncertainties calculated from the sum of squared deviations, provides a rigorous framework for comparing the performance of different aptamer-to-thiol ratios and for establishing the analytical figures of merit. The authors’ decision to perform the optimization study in quadruplicate and the stability analysis in triplicate, with analytical curves obtained in sextuplicate for each target concentration, indicates a level of replication that allows meaningful assessment of measurement variability. This replication is essential for distinguishing true analytical signals from random fluctuations, particularly in the serum matrix where biological variability and nonspecific interactions can introduce additional sources of noise.

The demonstration that this platform operates effectively in both simple and complex media positions it within a class of biosensors that could serve as templates for future diagnostic development. The combination of aptamer-based recognition, capacitive transduction, and surface-coupled redox labels offers a modular architecture in which each component can be independently optimized. The aptamer sequence can be redesigned for different targets, the monolayer composition can be adjusted to tune surface density and blocking efficiency, and the measurement protocol can be refined to extract additional information from the spectroscopic data. The authors’ focus on analytical parameters such as sensitivity, limit of detection, limit of quantification, linear range, and stability provides a comprehensive account of the platform’s capabilities and establishes a baseline against which future improvements can be measured.

The connection between this experimental platform and the theoretical frameworks being developed for quantum-scale biosensing suggests several directions for future investigation. The capacitive response of the electrode/electrolyte interface, as measured by ECS, depends on the density of electronic states at the surface and the rates of charge transfer between the redox label and the electrode. As biomolecular binding events alter the local environment of the redox label, they modulate these parameters in ways that could be interpreted through classical adsorption models or, alternatively, through frameworks that incorporate quantum mechanical descriptions of electronic transport. The authors note that some studies have demonstrated that capacitive systems can be treated from a quantum perspective, in which biomolecular interactions modulate parameters associated with state density and effective response rates, allowing the diagnostic signal to be analyzed through statistical metrics and classification criteria rather than relying exclusively on absolute capacitive parameters. The present work, by establishing a well-characterized experimental system with quantified analytical performance, provides a foundation upon which such alternative interpretations could be evaluated.

The reported sensitivity values, expressed as percentage change per decade of concentration, offer a convenient metric for comparing this platform with other capacitive biosensors. The values of approximately 0.2% per decade indicate that the capacitive response changes modestly but measurably across the five-order-of-magnitude linear range, which is consistent with the expected behavior of a monolayer-based sensor where the fraction of occupied recognition sites varies logarithmically with concentration. This logarithmic dependence is characteristic of surface binding equilibria and provides a physical basis for the linear relationship between the analytical signal and the logarithm of concentration that underpins the reported sensitivity metric.

The use of commercial human serum as the complex matrix for testing, rather than patient samples, represents both a strength and a limitation of the present study. Commercial serum provides a standardized and reproducible matrix that allows rigorous comparison of sensor performance across different preparation batches and measurement sessions. However, patient samples contain additional variables, including varying levels of endogenous proteins, antibodies, and metabolites, that could introduce further complexity. The authors’ demonstration of robustness in commercial serum establishes a necessary but not sufficient condition for clinical deployment, and further validation in patient samples would be required to confirm the platform’s diagnostic utility. The consistency between buffer and serum performance reported here suggests that the monolayer architecture provides a solid foundation for such future validation efforts.

The integration of aptamer-based recognition with capacitive spectroscopy in this study illustrates how advances in biorecognition chemistry and electrochemical measurement techniques can converge to produce biosensors with clinically relevant performance. The five-decade linear range, the consistency between simple and complex media, and the quantified limits of detection establish a comprehensive analytical profile that positions this platform as a viable candidate for further development. The authors’ attention to the theoretical frameworks emerging from quantum-scale research, combined with their rigorous experimental characterization, reflects a balanced approach that acknowledges both the practical achievements of the present work and the conceptual directions in which the field is moving. As biosensor technology continues to evolve toward higher sensitivity and broader applicability, the principles demonstrated here, including surface-coupled redox labels, optimized monolayer composition, and capacitive transduction, are likely to remain relevant components of future diagnostic architectures.

Subject of Research: …

Article Title: Quantum-biological interface in biosensor design: detecting proteins with electrochemical aptasensor

Article References: Costa, L. P. C., Batistuti Sawazaki, M. R., Bachour Junior, B., & Mulato, M. (2026). Quantum-biological interface in biosensor design: detecting proteins with electrochemical aptasensor. Frontiers in Photonics, 7, Article 1714572. https://doi.org/10.3389/fphot.2026.1714572

Image Credits: AI Generated

DOI: 10.3389/fphot.2026.1714572

Keywords: Quantum-biological, interface, biosensor, design, detecting, proteins, electrochemical, aptasensor, scientific research